Literature DB >> 6690620

Effect of iron (III) in the presence of various ligands on the phagocytic and metabolic activity of human polymorphonuclear leukocytes.

B S van Asbeck, J J Marx, A Struyvenberg, J H van Kats, J Verhoef.   

Abstract

FeCl3 or Fe(III) that attached to chelating ligands such as citrate or nitrilotriacetic acid (NTA) at a molar ratio of 1:1 had a toxic effect on PMN. Uptake of radiolabeled Staphylococcus aureus by PMN, preincubated for 2 hr at 37 degrees C in a medium containing Fe(III)-citrate or Fe(III)-NTA, was significantly lower than that of control PMN preincubated without excess iron (p less than 0.002). However, at a 1:2 molar ratio of Fe(III) to citrate or NTA, the iron was not toxic. In contrast, the iron-liganding molecules transferrin and deferoxamine protected the PMN against the noxious effect of iron at concentrations just high enough to sequester all the iron. Fe(III) increased the generation of luminol chemiluminescence by stimulated PMN, whereas the oxygen consumption of the cells was not altered in the presence of Fe(III); this suggests a catalytic effect of iron on the production by PMN of oxygen metabolites at some step beyond the formation of superoxide. No effect of iron was observed when the incubation was performed at 4 degrees C, nor when an oxygen-radical scavenger such as thiourea, mannitol, or catalase was present in the incubation medium. Also, Fe(III) had much less effect on the phagocytic function of PMN of a patient with chronic granulomatous disease. The results indicate that the Fe(III)-induced defect in the phagocytic capacity of PMN depends on the nature and the concentration of the ligand attached to the iron ion, and also suggest that the noxious effect of iron on the PMN function is a result of its ability to catalyze the generation of toxic oxygen species by these cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6690620

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Nutritional aspects of immunosuppression in athletes.

Authors:  N C Bishop; A K Blannin; N P Walsh; P J Robson; M Gleeson
Journal:  Sports Med       Date:  1999-09       Impact factor: 11.136

Review 2.  Immune cell functions in iron overload.

Authors:  M de Sousa
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

3.  Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy.

Authors:  M Tanaka; H Kanamori; K Matsumoto; T Tachibana; A Numata; K Ohashi; T Kobayashi; C Nakaseko; Y Kanda; E Yamazaki; S Fujisawa; J Ooi; T Sakura; N Aotsuka; M Onoda; S Machida; J Kato; K Usuki; R Watanabe; J Taguchi; S Yano; T Saito; S Takahashi; H Sakamaki; S Okamoto
Journal:  Bone Marrow Transplant       Date:  2015-03-02       Impact factor: 5.483

4.  Chronic use of oral iron supplements is associated with poor clinical outcomes in patients with gram-negative bacteremia.

Authors:  Alaa Atamna; Hani Hamud; Waseem Daud; Tzippy Shochat; Jihad Bishara; Avishay Elis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-01-26       Impact factor: 3.267

Review 5.  Iron and infection in hemodialysis patients.

Authors:  Julie H Ishida; Kirsten L Johansen
Journal:  Semin Dial       Date:  2013-12-12       Impact factor: 3.455

6.  Influence of superoxide dismutase on staphylococcal arthritis--a histological and biochemical investigation using an experimental animal model.

Authors:  W E Linhart; G Steinwender; W Weybora; S Zadravec; H Esterbauer
Journal:  Agents Actions       Date:  1990-03

7.  Psychological and immunological correlates of acute overtraining.

Authors:  R W Fry; J R Grove; A R Morton; P M Zeroni; S Gaudieri; D Keast
Journal:  Br J Sports Med       Date:  1994-12       Impact factor: 13.800

8.  Non-transferrin bound iron and neutropenia after cytotoxic chemotherapy.

Authors:  P Harrison; S S Marwah; R T Hughes; D Bareford
Journal:  J Clin Pathol       Date:  1994-04       Impact factor: 3.411

9.  Modulation of exudate inflammation parameters in rat carrageenan-induced granuloma by modification of exudate iron levels.

Authors:  J Muntane; P Fritsch; T Carbonell; M P Saiz; P Puig-Parellada; M T Mitjavila
Journal:  Agents Actions       Date:  1991-03

10.  Role of iron chelators in growth-promoting effect on mouse hybridoma cells in a chemically defined medium.

Authors:  N Yabe; M Kato; Y Matsuya; I Yamane; M Iizuka; H Takayoshi; K Suzuki
Journal:  In Vitro Cell Dev Biol       Date:  1987-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.